• GTP Solution for Precision mRNA Workflows

  2026-08-31

  A controlled 100 mM GTP stock supports reproducible in vitro transcription, from p21 mRNA production to lipid nanoparticle testing. This practical guide connects nucleotide handling and assay optimization with the localized mRNA-LNP strategy reported for bladder cancer.

• Precision PCR for Neurodegeneration Research

  2026-08-31

  A translational framework for using high-fidelity PCR to validate the genetic and molecular circuitry linking early pheromone perception to adult neurodegeneration in C. elegans.

• Amitriptyline HCl in BBB Assay Design

  2026-08-30

  Amitriptyline HCl can serve as a mechanistic probe for receptor biology and CNS assay interpretation. This guide connects B2231 handling with a high-throughput BBB model, emphasizing lysosomal trapping, efflux, recovery, and decision quality rather than simple permeability ranking.

• Ion Supplementation Improves CPP Nucleic Acid Delivery

  2026-08-29

  The reference study shows that inorganic ions can tune the size, charge, stability, and biological performance of cell-penetrating peptide–nucleic acid nanoparticles. Its central implication is that ion selection can improve productive delivery primarily by promoting endosomal escape, rather than simply increasing cellular internalization.

• Mithramycin A in Transcription Assays

  2026-08-28

  Mithramycin A converts metal-dependent binding to G-C-rich DNA into a practical perturbation tool for c-myc, differentiation, and transcription studies. This workflow-focused guide also shows how to evaluate its carefully bounded use in doxorubicin-induced cardiac injury models without confusing a broad DNA-binding probe with a pathway-specific inhibitor.

• Senescent Beta Cells and Type 1 Diabetes: Study Insights

  2026-08-28

  Thompson et al. showed that a subset of pancreatic beta cells becomes senescent during type 1 diabetes and develops a secretory phenotype that may intensify immune-mediated damage. By targeting the Bcl-2-dependent survival of these cells, the study preserved beta-cell mass and prevented diabetes in NOD mice, providing a mechanistic basis for senolytic research in T1D.

• DiD (DiDC 18 (5)) for Membrane Tracking

  2026-08-27

  DiD (DiDC 18 (5)) delivers far-red plasma membrane labeling for cell migration tracking, neuronal tracing, fusion assays, and imaging in autofluorescent tissues. This practical guide connects its workflow to macrophage-centered diabetic periodontitis research while clearly separating validated product properties from assay-development recommendations.

• Sodium-Driven Mitochondrial Energy Failure in NECSO

  2026-08-27

  Qiao et al. identify a mechanistic link between TRPM4-dependent sodium influx, mitochondrial ion imbalance, impaired oxidative metabolism, and necrosis by sodium overload. The study shows why mitochondrial energy measurements, including membrane-potential readouts, can complement endpoint cell-death assays when investigating sodium-driven injury.

• Maraviroc: A CCR5-Centered Assay Strategy

  2026-08-26

  Maraviroc and UK-427857 enable precise interrogation of CCR5 biology across HIV-1 entry and neuroinflammation models. This guide focuses on a time- and compartment-aware assay strategy that connects receptor pharmacology with inflammatory readouts without overstating translational evidence.

• Bromodomain Inhibitor, (+)-JQ1: Applied Workflows

  2026-08-26

  Bromodomain Inhibitor, (+)-JQ1 provides a practical way to perturb BET-dependent transcription in adipogenesis, leukemia apoptosis, inflammatory signaling, and BRDT-linked reproductive biology. This workflow-centered guide connects dose design, orthogonal validation, assay controls, and troubleshooting to the latest evidence on super-enhancer-driven KLF6 expression.

• Proteoform-Specific Drug Interactions in Native Membranes

  2026-08-25

  Lutomski and colleagues developed a native mass-spectrometry workflow that releases membrane proteins and signaling complexes directly from retinal disc membranes, preserving links between post-translational modifications, membrane association, and ligand binding. Their analysis of rhodopsin, G proteins, PDE6, sildenafil, and vardenafil shows why proteoform-resolved measurements can reveal drug interactions that conventional cell assays and bottom-up proteomics may obscure.

• PXR Activation, Liver Regeneration, and CYP Activity

  2026-08-25

  This rat study shows that activating the pregnane X receptor with pregnenolone-16α-carbonitrile can promote liver enlargement and regeneration while increasing the functional activity and protein expression of CYP3A1/2 and CYP2C6/11. Its cocktail pharmacokinetic design separates liver mass recovery from drug-metabolizing capacity, offering a useful framework for evaluating hepatic function during regeneration.

• Radicicol Beyond Hsp90: A Translational Research Strategy

  2026-08-24

  Radicicol is more than a conventional Hsp90 inhibitor: its ATPase and kinase activity profile provides a versatile perturbation tool for connecting proteostasis, metabolism, apoptosis, adipogenesis, and inflammatory biology. This thought-leadership guide shows how to position Radicicol alongside the LKB1–AMPK findings reported in inflamed periodontal ligament stem cells, while clearly separating evidence-supported applications from forward-looking hypotheses.

• Resazurin Sodium Salt for Smarter Viability Readouts

  2026-08-24

  Resazurin sodium salt is a fluorogenic oxidation-reduction indicator whose signal reflects cellular redox activity rather than cell number alone. This guide explains how to interpret it alongside functional models, including iPSC-derived airway assays for cystic fibrosis drug testing.

• NETs in CML: TKI Effects and Vascular Risk

  2026-08-23

  Telerman and colleagues show that neutrophil extracellular traps (NETs) are elevated in treatment-naïve chronic myeloid leukemia (CML) and can be differentially modulated by tyrosine kinase inhibitors. Their patient-cell and BCR-ABL1-transduced HoxB8 models connect leukemic signaling, PAD4-dependent NET biology, and the potential vascular toxicity of selected therapies.

7980 records 1/532 page Next 12345 下5页 Last page